作者: Kieron Dunleavy , Catherine M. Bollard
DOI: 10.1182/BLOOD-2010-11-317131
关键词:
摘要: In this issue of Blood , Castellino and colleagues investigate morbidity mortality in a cohort long-term survivors Hodgkin lymphoma (HL) from the Childhood Cancer Survivor Study. They observe frequent serious late sequelae therapy occurring even after 20 years follow-up; their findings highlight need to consider implications when selecting therapeutic strategies for young patients with curable lymphomas.